FENNEC PHARMACEUTICALS INC. - Common Shares (FENC)

Historical Holders from Q3 2017 to Q3 2025

Symbol
FENC on Nasdaq
CUSIP
31447P100
Type / Class
Equity / Common Shares
Shares outstanding
27.7M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
13.9M
Holdings value
$130M
% of all portfolios
0.005%
Grand Portfolio weight change
+0%
Number of holders
83
Number of buys
36
Number of sells
-30
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Solas Capital Management, LLC 8.2% +17.1% $12.8M $1.86M 2.25M +17% Solas Capital Management, LLC Dec 31, 2024
Rosalind Advisors, Inc. 7.5% $19.4M 2.08M Rosalind Advisors, Inc. Sep 30, 2025
DG Capital Management, LLC 4.1% $6.34M 1.11M DG Capital Management, LLC Dec 31, 2024

Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 13.9M $130M +$2.61M $9.36 83
2025 Q2 13.6M $113M +$2.37M $8.30 77
2025 Q1 13.4M $81.6M -$1.52M $6.09 68
2024 Q4 16M $101M +$7.28M $6.32 64
2024 Q3 14.9M $74.7M +$2.54M $5.00 62
2024 Q2 14.4M $87.7M -$6.4M $6.11 62
2024 Q1 14.5M $161M -$6.1M $11.12 64
2023 Q4 15M $168M +$8.24M $11.22 56
2023 Q3 14.3M $107M +$1.44M $7.51 55
2023 Q2 14.1M $124M +$9.44M $8.83 54
2023 Q1 13M $108M +$4.71M $8.32 53
2022 Q4 12.5M $120M -$8.64M $9.60 42
2022 Q3 11.4M $92.1M +$914K $8.10 33
2022 Q2 11.3M $63.1M -$836K $5.63 24
2022 Q1 11.4M $64M +$542K $5.60 24
2021 Q4 11.3M $49.9M -$2.43M $4.40 26
2021 Q3 11.6M $110M -$3.04M $9.42 31
2021 Q2 12.1M $88M -$14.2M $7.29 37
2021 Q1 14.4M $89.3M -$593K $6.21 49
2020 Q4 14.5M $108M +$5.05M $7.45 48
2020 Q3 13.8M $83.8M -$1.13M $6.06 51
2020 Q2 13.9M $116M +$37.9M $8.35 54
2020 Q1 9.46M $56.2M +$983K $5.94 26
2019 Q4 9.29M $60.3M -$38.1K $6.48 25
2019 Q3 8.47M $40.7M -$1.96M $4.81 20
2019 Q2 8.99M $36M -$3.1M $4.00 25
2019 Q1 9.64M $46.7M -$526K $4.85 43
2018 Q4 9.74M $62.2M +$1.86M $6.38 44
2018 Q3 9.44M $77.4M -$277K $8.20 44
2018 Q2 9.39M $98.1M +$18.2M $10.44 42
2018 Q1 7.62M $92.2M +$4.86M $12.09 20
2017 Q4 6.95M $69.6M +$18M $10.02 15
2017 Q3 5.21M $57.7M +$57.7M $11.08 9